Ara
Toplam kayıt 2, listelenen: 1-2
The View of Turkish Oncologists Regarding MSI Status and Tumor Localization in Stage II and III Colon Cancer
(Springer, 2020)
Introduction: Although several clinical factors which show the benefit of adjuvant chemotherapy (AC) in early-stage colon cancer use for evaluating the risk of relapse, there is no consensus on which risk factors are more ...
The Real-Life Data of BRAF Mutation on the Treatment of Colorectal Cancer: a TOG Study
(Springer, 2021)
Purpose Colorectal cancer is the third leading diagnosis accounting for nearly 10% of all new cancers worldwide. The distinct features among BRAF mutant colorectal cancers make these tumor groups hard to treat for oncologists. ...